Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin W Ng

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Molecular Cancer|October 28, 2016
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisErin A Marshall, Kevin W Ng, Sonia H Y Kung, et al.
Ebiomedicine|April 16, 2021
The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF)Feng Xu, Naoya Tanabe, Dragos M Vasilescu, et al.
Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Med (New York, N.Y.)|August 20, 2021
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseasesClaire T Deakin, Georgina H Cornish, Kevin W Ng, et al.
Science Advances|April 23, 2021
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunityAnnachiara Rosa, Valerie E Pye, Carl Graham, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
SARS-CoV-2 recruits a haem metabolite to evade antibody immunityAnnachiara Rosa, Valerie E Pye, Carl Graham, et al.
Science (New York, N.Y.)|November 7, 2020
Preexisting and de novo humoral immunity to SARS-CoV-2 in humansKevin W Ng, Nikhil Faulkner, Georgina H Cornish, et al.
Nature|April 12, 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Molecular Cancer|October 28, 2016
Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasisErin A Marshall, Kevin W Ng, Sonia H Y Kung, et al.
Ebiomedicine|April 16, 2021
The transition from normal lung anatomy to minimal and established fibrosis in idiopathic pulmonary fibrosis (IPF)Feng Xu, Naoya Tanabe, Dragos M Vasilescu, et al.
Elife|July 29, 2021
Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strainsNikhil Faulkner, Kevin W Ng, Mary Y Wu, et al.
Cancer Research|August 5, 2022
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy CombinationsJesse Boumelha, Sophie de Carné Trécesson, Emily K Law, et al.
Med (New York, N.Y.)|August 20, 2021
Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseasesClaire T Deakin, Georgina H Cornish, Kevin W Ng, et al.
Science Advances|April 23, 2021
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunityAnnachiara Rosa, Valerie E Pye, Carl Graham, et al.
Medrxiv : the Preprint Server for Health Sciences|February 3, 2021
SARS-CoV-2 recruits a haem metabolite to evade antibody immunityAnnachiara Rosa, Valerie E Pye, Carl Graham, et al.
Science (New York, N.Y.)|November 7, 2020
Preexisting and de novo humoral immunity to SARS-CoV-2 in humansKevin W Ng, Nikhil Faulkner, Georgina H Cornish, et al.
Nature|April 12, 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature Cancer|February 5, 2022
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE studyAnnika Fendler, Lewis Au, Scott T C Shepherd, et al.
Pageof 4